Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

NCT06098079 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

8600

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Naltrexone-Bupropion (NB) Combination
DRUG: Placebo

Sponsor

Currax Pharmaceuticals